191 related articles for article (PubMed ID: 30178654)
1. Metal-Organic Framework-Based Nanoplatform for Intracellular Environment-Responsive Endo/Lysosomal Escape and Enhanced Cancer Therapy.
Dong K; Wang Z; Zhang Y; Ren J; Qu X
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31998-32005. PubMed ID: 30178654
[TBL] [Abstract][Full Text] [Related]
2. Facile preparation of metal-organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment.
Dong K; Zhang Y; Zhang L; Wang Z; Ren J; Qu X
Talanta; 2019 Mar; 194():703-708. PubMed ID: 30609594
[TBL] [Abstract][Full Text] [Related]
3. Photomediated Reactive Oxygen Species-Generable Nanoparticles for Triggered Release and Endo/Lysosomal Escape of Drug upon Attenuated Single Light Irradiation.
Seo EH; Lee CS; Na K
Adv Healthc Mater; 2015 Dec; 4(18):2822-30. PubMed ID: 26449186
[TBL] [Abstract][Full Text] [Related]
4. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
[TBL] [Abstract][Full Text] [Related]
5. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
[TBL] [Abstract][Full Text] [Related]
6. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery.
Panyam J; Zhou WZ; Prabha S; Sahoo SK; Labhasetwar V
FASEB J; 2002 Aug; 16(10):1217-26. PubMed ID: 12153989
[TBL] [Abstract][Full Text] [Related]
7. Carbon Dots Embedded Magnetic Nanoparticles @Chitosan @Metal Organic Framework as a Nanoprobe for pH Sensitive Targeted Anticancer Drug Delivery.
Chowdhuri AR; Singh T; Ghosh SK; Sahu SK
ACS Appl Mater Interfaces; 2016 Jul; 8(26):16573-83. PubMed ID: 27305490
[TBL] [Abstract][Full Text] [Related]
8. Metal organic framework coated MnO
Nie Y; Li D; Peng Y; Wang S; Hu S; Liu M; Ding J; Zhou W
Int J Pharm; 2020 Jul; 585():119513. PubMed ID: 32526334
[TBL] [Abstract][Full Text] [Related]
9. A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles.
Wang J; Bhattacharyya J; Mastria E; Chilkoti A
J Control Release; 2017 Aug; 260():100-110. PubMed ID: 28576641
[TBL] [Abstract][Full Text] [Related]
10. Biomineralized Metal-Organic Framework Nanoparticles Enable Intracellular Delivery and Endo-Lysosomal Release of Native Active Proteins.
Chen TT; Yi JT; Zhao YY; Chu X
J Am Chem Soc; 2018 Aug; 140(31):9912-9920. PubMed ID: 30008215
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC.
Chen P; Yang W; Hong T; Miyazaki T; Dirisala A; Kataoka K; Cabral H
Biomaterials; 2022 Sep; 288():121748. PubMed ID: 36038419
[TBL] [Abstract][Full Text] [Related]
12. A Photoactivatable AIE Polymer for Light-Controlled Gene Delivery: Concurrent Endo/Lysosomal Escape and DNA Unpacking.
Yuan Y; Zhang CJ; Liu B
Angew Chem Int Ed Engl; 2015 Sep; 54(39):11419-23. PubMed ID: 26094980
[TBL] [Abstract][Full Text] [Related]
13. Targeted VEGF-triggered release of an anti-cancer drug from aptamer-functionalized metal-organic framework nanoparticles.
Chen WH; Yang Sung S; Fadeev M; Cecconello A; Nechushtai R; Willner I
Nanoscale; 2018 Mar; 10(10):4650-4657. PubMed ID: 29465130
[TBL] [Abstract][Full Text] [Related]
14. Construction of an iridium(iii)-complex-loaded MOF nanoplatform mediated with a dual-responsive polycationic polymer for photodynamic therapy and cell imaging.
Zhang Y; Fu H; Chen S; Liu B; Sun W; Gao H
Chem Commun (Camb); 2020 Jan; 56(5):762-765. PubMed ID: 31845680
[TBL] [Abstract][Full Text] [Related]
15. Inorganic and Metal-Organic Nanocomposites for Cascade-Responsive Imaging and Photochemical Synergistic Effects.
Hu X; Zhu Z; Dong H; Zhu X; Zhu H; Ogawa K; Odani A; Koh K; Chen H
Inorg Chem; 2020 Apr; 59(7):4617-4625. PubMed ID: 32207928
[TBL] [Abstract][Full Text] [Related]
16. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
[TBL] [Abstract][Full Text] [Related]
17. A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy.
Duan F; Feng X; Yang X; Sun W; Jin Y; Liu H; Ge K; Li Z; Zhang J
Biomaterials; 2017 Apr; 122():23-33. PubMed ID: 28107662
[TBL] [Abstract][Full Text] [Related]
18. Reporter assay for endo/lysosomal escape of toxin-based therapeutics.
Gilabert-Oriol R; Thakur M; von Mallinckrodt B; Bhargava C; Wiesner B; Eichhorst J; Melzig MF; Fuchs H; Weng A
Toxins (Basel); 2014 May; 6(5):1644-66. PubMed ID: 24859158
[TBL] [Abstract][Full Text] [Related]
19. Rational Design of Metal Organic Framework Nanocarrier-Based Codelivery System of Doxorubicin Hydrochloride/Verapamil Hydrochloride for Overcoming Multidrug Resistance with Efficient Targeted Cancer Therapy.
Zhang H; Jiang W; Liu R; Zhang J; Zhang D; Li Z; Luan Y
ACS Appl Mater Interfaces; 2017 Jun; 9(23):19687-19697. PubMed ID: 28530401
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy.
Sun Y; Sha Y; Cui G; Meng F; Zhong Z
Adv Drug Deliv Rev; 2023 Jan; 192():114624. PubMed ID: 36435229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
